Bioceres reports $179 million impairment after pro farm foreclosure as company pursues refinancing

Bioceres Crop Solutions said it recorded a $179 million impairment following the foreclosure of assets tied to its Pro Farm business, after creditors submitted a $15 million bid for collateral whose carrying value had been about $194 million. The foreclosure auction took place on January 20, 2026, and the company said it is pursuing legal remedies, arguing the process was not conducted on commercially reasonable terms. The assets, largely tied to operations in the United States and Europe, have been classified as discontinued operations.

Chief executive Federico Trucco told shareholders that the company’s continuing business—centered on Argentina and its biotechnology platforms—has faced pressure from weak commodity prices and tighter credit conditions affecting farmers in its core market. Despite the challenging environment, Bioceres said its crop protection, crop nutrition, and seed segments maintained a consolidated gross margin of about 40% year-to-date, in line with the prior year.

The company also disclosed that substantial doubt remains about its ability to continue as a going concern while it seeks additional financing. Bioceres said it is negotiating with Argentine lenders to refinance obligations and evaluating asset sales and longer-term funding options. In February, subsidiary Rizobacter Argentina refinanced its Series VIII Class B corporate bonds, extending their maturity, which the company described as a positive signal of continued access to local capital markets.